AKT1 and glioblastoma: Specifically, Cheng and colleagues [43] demonstrated that the AS1411 aptamer by binding NCL decreased GBM cell proliferation, with p53 and cyclin A1 upregulation and Bcl-2, Akt1, and cyclin B1 downregulation.